Numerous studies have demonstrated that the involvement of TGF-β1 in atherosclerosis plays a key role by inhibiting inflammation and increasing atherosclerotic plaque stabilization, and hence appears to be anti-atherogenic [12-14]. This evidence concerns the gene TGFB1 and atherosclerosis.